Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
14 hedge funds and large institutions have $71.6K invested in Liminal BioSciences Inc. Common Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.
7% less funds holding
Funds holding: 15 → 14 (-1)
29% less capital invested
Capital invested by funds: $101K → $71.6K (-$29.1K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.19K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.51K |
| 2 |
Two Sigma Advisers
New York
|
-$5K |
| 3 |
Renaissance Technologies
New York
|
-$4.52K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$2.13K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$123 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
National Bank of Canada
Montreal,
Quebec, Canada
| $31.6K | -$123 | -27 | -0.3% |
|
|
2
Renaissance Technologies
New York
| $13K | -$4.52K | -989 | -20% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $10.5K | -$2.13K | -466 | -13% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $7K | – | – | – |
|
|
5
Millennium Management
New York
| $4K | +$5.19K | +1,135 | New |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | -$5.51K | -1,205 | -70% |
|
|
ECM
7
Estabrook Capital Management
New York
| $1.63K | – | – | – |
|
|
IA
8
IFP Advisors
Tampa,
Florida
| $1K | -$55 | -12 | -92% |
|
|
9
UBS Group
Zurich,
Switzerland
| $803 | +$1.11K | +242 | +24,200% |
|
10
Group One Trading
Chicago,
Illinois
| $33 | -$105 | -23 | -70% |
|
|
TWC
11
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $26 | – | – | – |
|
12
Morgan Stanley
New York
| $20 | – | – | – |
|
|
13
Two Sigma Advisers
New York
| – | -$5K | -1,080 | Closed |
|
LMNL Hedge Fund Activity: Q4 2022 in Review
14 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q4 2022, worth a combined $71.6K — down 29% from $101K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LMNL and 1 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 1 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $5.19K. The largest seller was Royal Bank of Canada, cutting an estimated $5.51K.
- 14 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q4 2022, down from 15 in Q3 2022.
- Funds reported $71.6K of Liminal BioSciences Inc. Common Shares stock for Q4 2022, down 29% quarter-over-quarter.
- 1 fund opened new Liminal BioSciences Inc. Common Shares positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest Liminal BioSciences Inc. Common Shares buyer in Q4 2022 was Millennium Management, an estimated $5.19K added.
- The largest Liminal BioSciences Inc. Common Shares seller in Q4 2022 was Royal Bank of Canada, an estimated $5.51K sold.
Based on aggregated 13F filings for Q4 2022.